Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ROZH PHARMA AS
AS
Active
Org 929046579
Grimseidvegen 437D, 5259
Hjellestad
Retail sale of pharmaceutical products
· NACE 4773
Est. 2022
8 employees
Watchlist
Share
Norway
/
Companies
/
Retail sale of pharmaceutical products
/
ROZH PHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
7M
13M
20M
26M
4M
2022
20M
2023
23M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
1M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
3 901
20 492
22 519
Staff expenses
−527
−2 671
−2 789
EBITDA
461
1 183
1 481
Depreciation & amort.
−16
−62
−62
EBIT
446
1 120
1 418
Net financials
−36
−93
−75
Profit before tax
409
1 027
1 343
Tax
89
226
297
Net profit
321
802
1 047
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
4 933
5 702
4 472
Equity
345
347
1 093
Long-term debt
1 539
1 300
694
Short-term debt
3 049
4 056
2 684
Total debt
4 588
5 356
3 379
Financial ratios
5-year trend
EBITDA margin
6.6%
This company
15.8%
Market median
-58% vs market
2022
2024
Equity ratio
24.4%
This company
38.2%
Market median
-36% vs market
2022
2024
Return on equity
95.7%
This company
18.4%
Market median
+420% vs market
2022
2024
Net profit margin
4.6%
This company
8.1%
Market median
-43% vs market
2022
2024
Asset turnover
5.04×
This company
1.12×
Market median
+350% vs market
2022
2024
Debt / equity
3.09×
This company
0.62×
Market median
-398% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-03-16 – 2022-12-31
View
PDF
More on ROZH PHARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
